Last reviewed · How we verify
NCT04979104
Hip Arthroplasty With SL Cementless
trial testing Hip arthroplasty with SL Cementless in Hip Replacement in 60 participants. Completed in 11 December 2023.
11 December 2023
Quick facts
| Lead sponsor | Limacorporate S.p.a |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 8 June 2021 |
| Primary completion | 11 December 2023 |
| Estimated completion | 11 December 2023 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Hip arthroplasty with SL Cementless
Conditions studied
- Hip Replacement — all drugs for Hip Replacement →
Sponsor
Limacorporate S.p.a
Who can join
18 and older, any sex, with Hip Replacement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to evaluate the clinical, radiographical and patient-reported outcomes measurements up 3 years FU and to assess the survivorship of SL Cementless Stem after partial or total hip arthroplasty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04979104
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Replacement
Currently open trials in the same condition.
- NCT06172569 — Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Study · recruiting
Other Limacorporate S.p.a trials
Trials by the same sponsor.
- NCT05180071 — A Post-market Study Evaluating Clinical and Radiographic Outcomes of Total Elbow Arthroplasty With TEMA · NA · not yet recruiting
- NCT05606120 — H-35 CL TRAUMA Cemented Femoral Stem · completed
- NCT05007067 — H-29 DELTA Multihole TT Study. · terminated
- NCT06870123 — Randomized MINIMA Stem with DELTA TT or DELTA ST-C · NA · active not recruiting
- NCT04884542 — Multigen Plus H Study and AMF TT Cones · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04979104 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Limacorporate S.p.a
- Last refreshed: 10 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04979104.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing